Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00316602
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2006-04-20
Brief Title:
A Phase II Study on Immunogenicity and Safety of MVA-BN IMVAMUNE Smallpox Vaccine in Subjects With Atopic Dermatitis
Sponsor:
Bavarian Nordic
Organization:
Bavarian Nordic